No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. It operates through the following segments: Pharmaceuticals, Wholesale & Retail, and Others. The Pharmaceutical segment engages in research and development, manufacturing, sales and marketing of pharmaceutical products. The Wholesale & Retail segment represents the distribution of companies and pharmacies that are part of the sales network in various regional markets and, as such, convey its products to consumers. The Other segment relates to the business of the members of the group that provide marketing and sales support services. The company was founded by Gedeon Richter in 1901 and is headquartered in Budapest, Hungary.
www.gedeonrichter.comNo one on the platform currently holds RICHT.BD.
No tracked institution reports a position in RICHT.BD as of their last filing.
No one on the platform has traded RICHT.BD yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 20.1% | 16.7% | 13.5% | — | — | — |
| Rev. Growth % | 8.3% | 10.4% | ||||
| Profit Margin % | 25.0% | 23.2% | 17.1% | |||
| Free Cash Flow Margin % | 26.9% | 18.7% | 15.9% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $963.9B | +5.2% | $1451.24 | $1451.24–$1451.24 | — | 1 |
| 2027 | $1.01T | +4.4% | $1664.31 | $1664.31–$1664.31 | — | 1 |
| 2028 | $1.12T | +10.8% | $1814.54 | $1814.54–$1814.54 | — | 1 |
| 2029 | $1.11T | -0.6% | $1910.00 | $1910.00–$1910.00 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep